Regulation of heat-induced apoptosis by Mcl-1 degradation and its inhibition by Hsp70
/in Hyperthermia, International PublicationsHyperthermia-treated mesenchymal stem cells exert antitumor effects on human carcinoma cell line
/in Hyperthermia, International PublicationsAntigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approaches
/in Dendritic Cells, International PublicationsProlonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells
/in Dendritic Cells, International Publications, Malignant MelanomaEnhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death
/in Dendritic Cells, International PublicationsWhole blood selenium levels (WBSL) in patients with prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy male inhabitants (HMI) and prostatic tissue selenium levels (PTSL) in patients with PC and BPH
/in International Publications, Micronutrients, Prostate CancerNew therapeutic strategies in acute lymphoblastic leukemia
/in Acute Leukemia, International PublicationsDendritic cell-based immunotherapy in myeloid leukaemia: translating fundamental mechanisms into clinical applications
/in Acute Leukemia, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer